Vitamin E in humans: Demand and delivery

被引:369
作者
Traber, MG [1 ]
Sies, H [1 ]
机构
[1] UNIV DUSSELDORF, INST PHYSIOL CHEM 1, D-40001 DUSSELDORF, GERMANY
关键词
tocopherol; lipoproteins; chylomicrons; VLDL; LDL; HDL; tocopherol transfer protein; ataxia with vitamin E deficiency;
D O I
10.1146/annurev.nu.16.070196.001541
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
How much vitamin E is enough? An established use of supplemental vitamin E in humans is in the prevention and therapy of deficiency symptoms. The cause of vitamin E deficiency, characterized by peripheral neuropathy and ataxia, is usually malabsorption-a result of fat malabsorption or genetic abnormalities in lipoprotein metabolism. Genetic abnormalities in the hepatic alpha-tocopherol transfer protein also cause vitamin E deficiency-defects in this protein cause an impairment in plasma vitamin E transport. Impaired delivery of vitamin E to tissues, thereby, results in deficiency symptoms. Also discussed is the use of supplemental vitamin E in chronic diseases such as ischemic heart disease, atherosclerosis, diabetes, cataracts, Parkinson's disease, Alzheimer's disease, and impared immune function, as well as in subjects receiving total parenterol nutrition. In healthy individuals, a daily intake of about 15-30 mg of alpha-tocopherol is recommended to obtain ''optimal plasma alpha-tocopherol concentrations'' (30 mu M or greater).
引用
收藏
页码:321 / 347
页数:27
相关论文
共 158 条
  • [1] ALZHEIMERS AND PARKINSONS-DISEASE - BRAIN LEVELS OF GLUTATHIONE, GLUTATHIONE DISULFIDE, AND VITAMIN-E
    ADAMS, JD
    KLAIDMAN, LK
    ODUNZE, IN
    SHEN, HC
    MILLER, CA
    [J]. MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1991, 14 (03) : 213 - 226
  • [2] [Anonymous], 1991, OXIDATIVE STRESS OXI
  • [3] [Anonymous], 1989, REC DIET ALL
  • [4] HUMAN ALPHA-TOCOPHEROL TRANSFER PROTEIN - CDNA CLONING, EXPRESSION AND CHROMOSOMAL LOCALIZATION
    ARITA, M
    SATO, Y
    MIYATA, A
    TANABE, T
    TAKAHASHI, E
    KAYDEN, HJ
    ARAI, H
    INOUE, K
    [J]. BIOCHEMICAL JOURNAL, 1995, 306 : 437 - 443
  • [5] VITAMIN-E PROTECTS NERVE-CELLS FROM AMYLOID BETA-PROTEIN TOXICITY
    BEHL, C
    DAVIS, J
    COLE, GM
    SCHUBERT, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (02) : 944 - 950
  • [6] BELAL S, 1995, CLIN NEUROSCI, V3, P39
  • [7] BENDICH A, 1990, ADV EXP MED BIOL, V262, P35
  • [8] SAFETY OF ORAL INTAKE OF VITAMIN-E
    BENDICH, A
    MACHLIN, LJ
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1988, 48 (03) : 612 - 619
  • [9] LOCALIZATION OF FRIEDREICH ATAXIA PHENOTYPE WITH SELECTIVE VITAMIN-E-DEFICIENCY TO CHROMOSOME-8Q BY HOMOZYGOSITY MAPPING
    BENHAMIDA, C
    DOERFLINGER, N
    BELAL, S
    LINDER, C
    REUTENAUER, L
    DIB, C
    GYAPAY, G
    VIGNAL, A
    LEPASLIER, D
    COHEN, D
    PANDOLFO, M
    MOKINI, V
    NOVELLI, G
    HENTATI, F
    BENHAMIDA, M
    MANDEL, JL
    KOENIG, M
    [J]. NATURE GENETICS, 1993, 5 (02) : 195 - 200
  • [10] FRIEDREICH ATAXIA PHENOTYPE NOT LINKED TO CHROMOSOME-9 AND ASSOCIATED WITH SELECTIVE AUTOSOMAL RECESSIVE VITAMIN-E-DEFICIENCY IN 2 INBRED TUNISIAN FAMILIES
    BENHAMIDA, M
    BELAL, S
    SIRUGO, G
    BENHAMIDA, C
    PANAYIDES, K
    IONANNOU, P
    BECKMANN, J
    MANDEL, JL
    HENTATI, F
    KOENIG, M
    MIDDLETON, L
    [J]. NEUROLOGY, 1993, 43 (11) : 2179 - 2183